Tulsa Pro for Prostate Cancer | Laurence Klotz, MD, 2020 Prostate Cancer PCRI Conference

6 Views

07/07/23

PCRI's moderator, Mark Moyad, MD, MPH, asks Laurence Klotz, MD, about TULSA-PRO, a recently developed form of therapy that uses real-time MR imaging and ultrasound waves to thermally ablate prostate tissue. Studies are ongoing, but the hope is that this therapy will be used for partial-gland ablation and that the real-time MR imaging will provide greater precision than its closest comparable treatment, HIFU.

The PCRI will be hosting a webinar on TULSA-PRO with Mark Moyad, MD, and Laurence Klotz, MD, on October 17th. Visit our website to RSVP: https://pcri.org/tulsa-pro-webinar

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #MarkMoyadMD #LaurenceKlotzMD